Coya Therapeutics, Inc. · NASDAQ:COYA

Coya Therapeutics, Inc. financial statements

Coya Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020
Revenue7.95M3.55M6.00M00
Cost of revenue27.4K11.9M5.50M4.41M16.1K
Gross profit7.92M-8.31M500.7K-4.41M-16.1K
Research and development16.7M11.9M5.50M4.41M2.54M373.5K
Selling, general and administrative11.4M8.89M7.83M4.85M2.31M668.7K
Operating income-22.6M-17.2M-7.90M-9.81M-4.87M-1.04M
Depreciation and amortization27.4K27.4K27.4K27.4K16.1K704.7K
EBITDA-22.5M-17.2M-7.88M-9.78M-4.85M-337.5K
Interest expense2.43M21.5K39.0K
Income before tax-21.2M-15.6M-7.26M-12.2M-4.89M-1.10M
Income tax3.09K-720.3K723.9K0-21.5K-704
Net income-21.2M-14.9M-7.99M-12.2M-4.89M-1.10M
Earnings per share, basic-1.27-0.98-0.79-4.73-1.89-0.42
Earnings per share, diluted-1.27-0.98-0.79-4.73-1.89

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020
Cash and equivalents46.8M38.3M32.6M5.93M4.34M8.72M
Short-term investments38.3B
Receivables730.6K7.50M1.00K
Current assets49.9M44.3M41.2M7.18M4.58M8.75M
Property, plant and equipment11.2K38.6K65.9K93.3K120.7K
Total assets50.0M44.3M41.3M8.40M4.79M8.75M
Accounts payable1.06M1.59M1.16M1.82M857.6K447.1K
Current liabilities5.87M3.82M5.05M3.82M1.15M447.1K
Long-term debt13.0M
Total debt13.0M
Total liabilities6.92M4.77M5.63M16.8M1.15M447.1K
Shareholders' equity43.0M39.6M35.6M-8.39M3.64M8.30M
Shares outstanding20.9M16.7M14.4M2.59M2.59M2.59M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020
Cash from operations-10.7M-10.3M-11.2M-7.24M-3.90M-391.3K
Capital spending00-1-4-136.8K-4
Free cash flow-10.7M-10.3M-11.2M-7.24M-4.04M-391.3K
Cash from investing-1.16M-25.0K-543.2K-525.0K-136.8K-136.8K
Cash from financing20.4M16.0M38.4M9.36M-340.6K9.11M
Change in cash8.48M5.71M26.7M1.59M-4.38M8.72M